GW Pharmaceuticals announces pricing of common stock

|About: GW Pharmaceuticals plc (GWPH)|By:, SA News Editor

GW Pharmaceuticals (NASDAQ:GWPH) priced an underwritten public offering of 1.9M ADS, representing 22.8M ordinary shares, at a price of $158/ADS, raising gross proceeds of ~$300M.

Underwriters have a 30-day option to purchase up to an additional 0.285M ADSs.

Closing of the offering is expected to occur on 5 October, 2018.

Press Release

Subscribe for full text news in your inbox